首页>
外国专利>
USE OF AN ANGIOTENSIN ANTAGONIST (AT1) TO REDUCE POST-INFARITY MORBIDITY AND MORTALITY.
USE OF AN ANGIOTENSIN ANTAGONIST (AT1) TO REDUCE POST-INFARITY MORBIDITY AND MORTALITY.
展开▼
机译:使用血管紧张素拮抗药(AT1)来降低非传染性疾病后的死亡率和死亡率。
展开▼
页面导航
摘要
著录项
相似文献
摘要
THE INVENTION REFERS TO A METHOD FOR TREATING A HUMAN SURVIVOR OF AN ATTACK TO THE HEART AND PROVIDES AN ADDITIONAL IMPROVEMENT IN THE SURVIVAL THAT FOLLOWS THE CARDIAC INFARCTION BY THE EARLY INITIATION AND PROLONGED ADMINISTRATION OF AN INITIBORATORY SYSTEM OF ANGIENTENTHENTHYDHE RENTOR SYSTEM CONVERSION OF ANGIOTENSIN CONVERSION. THE INHIBITOR CAN BE USED ON ITSELF, OR IN CONJUNCTION WITH OTHER THERAPEUTIC COMPOUNDS SUCH AS BETA BLOCKERS AND THROMBOTIC AGENTS. THE PREFERRED INHIBITOR IS THE CAPTOPRILE.
展开▼